Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris

This guidance has been approved for use in Scotland by the Scottish Health Protection Network Guidance Group (SHPN-GG). The guidance sho​uld be used in conjunction with the SHPN addendum.

Candida auris is a recently identified Candida species that has been associated with infection and outbreaks in healthcare settings on five continents. It has been isolated from a range of body sites, including skin (very common), urogenital tract (common), and respiratory tract (occasional), and resulted in invasive infections, such as candidaemia, pericarditis, urinary tract infections and pneumonia.

C. auris affects both paediatric and adult populations, and has p​redominantly been identified in critically unwell patients in high dependency settings. As with other organisms associated with nosocomial outbreaks, it appears to be highly transmissible between patients and from contaminated environments, highlighting the importance of instituting effective infection prevention and control practices.

View the Guidance for the laboratory investigation, management a​​nd infection prevention and control for cases of Candida auris. ​